Nutritional status and primary tumour site in incurable cancer

2021 ◽  
pp. bmjspcare-2021-003321
Author(s):  
Livia Costa De Oliveira ◽  
Emanuelly Varea Maria Wiegert ◽  
Lara Azevedo dos Santos ◽  
Larissa Calixto-Lima

ObjectivesWe aimed (1) to assess the nutritional status (NS) using different methods, according to the primary tumour site and (2) to evaluate the performance of these methods in patients with incurable cancer from a reference centre in Brazil.MethodsCross-sectional analysis of data from patients admitted to the palliative care unit of a reference cancer centre in Brazil, between July 2016 and March 2020. The primary tumour site was the independent variable and the NS using different methods were the dependent variables. Logistic regressions were performed.ResultsA total of 2,144 patients were included in the study. The most common primary tumour site was the upper gastrointestinal (GI) tract (18.0%), followed by gynaecological (17.6%) and head and neck (HN) (13.5%). Our results showed that patients with tumours of the upper GI tract followed by HN presented significantly higher risk of worse NS. In contrast, breast tumours, bone and connective tissues and melanoma presented inverse association. The gynaecological cancer was variably associated with nutritional impairment, according to the assessment method.ConclusionsPatients with incurable cancer present high prevalence of NS impairment, depending on the tumour site, shown to be elevated in patients with tumour in the upper GI tract.

VideoGIE ◽  
2021 ◽  
Author(s):  
Yuan-Chen Wang ◽  
Jun Pan ◽  
Bin Jiang ◽  
Yang-Yang Qian ◽  
Xiao-Ou Qiu ◽  
...  

2006 ◽  
Vol 63 (5) ◽  
pp. AB246
Author(s):  
Pierre Eisendrath ◽  
Michel Cremer ◽  
Olivier Le Moine ◽  
Jacques Himpens ◽  
Guy-Bernard Cadiere ◽  
...  

Endoscopy ◽  
1990 ◽  
Vol 22 (S 1) ◽  
pp. 9-12 ◽  
Author(s):  
M. de Reuck ◽  
B. Ramdani ◽  
C. Jonas ◽  
J. F. Nyst ◽  
M. van Gossum ◽  
...  

2015 ◽  
Vol 148 (4) ◽  
pp. S-579
Author(s):  
Osman O. Ahsen ◽  
Hsiang-Chieh Lee ◽  
Kaicheng Liang ◽  
Michael G. Giacomelli ◽  
Zhao Wang ◽  
...  

Author(s):  
Yichen Wang ◽  
Pardeep Bansal ◽  
Si Li ◽  
Zaid Iqbal ◽  
Mahesh Cheryala ◽  
...  

2021 ◽  
Author(s):  
I Budimir ◽  
T Pavić ◽  
N Baršić ◽  
M Živković ◽  
V Ratkajec ◽  
...  

Endoscopy ◽  
2018 ◽  
Vol 51 (05) ◽  
pp. 409-418 ◽  
Author(s):  
Hey-Long Ching ◽  
Melissa F. Hale ◽  
Matthew Kurien ◽  
Jennifer A. Campbell ◽  
Stefania Chetcuti Zammit ◽  
...  

Abstract Background Small-bowel capsule endoscopy is advocated and repeat upper gastrointestinal (GI) endoscopy should be considered for evaluation of recurrent or refractory iron deficiency anemia (IDA). A new device that allows magnetic steering of the capsule around the stomach (magnetically assisted capsule endoscopy [MACE]), followed by passive small-bowel examination might satisfy both requirements in a single procedure. Methods In this prospective cohort study, MACE and esophagogastroduodenoscopy (EGD) were performed in patients with recurrent or refractory IDA. Comparisons of total (upper GI and small bowel) and upper GI diagnostic yields, gastric mucosal visibility, and patient comfort scores were the primary end points. Results 49 patients were recruited (median age 64 years; 39 % male). Combined upper and small-bowel examination using the new capsule yielded more pathology than EGD alone (113 vs. 52; P < 0.001). In upper GI examination (proximal to the second part of the duodenum, D2), MACE identified more total lesions than EGD (88 vs. 52; P < 0.001). There was also a difference if only IDA-associated lesions (esophagitis, altered/fresh blood, angioectasia, ulcers, and villous atrophy) were included (20 vs. 10; P = 0.04). Pathology distal to D2 was identified in 17 patients (34.7 %). Median scores (0 – 10 for none – extreme) for pain (0 vs. 2), discomfort (0 vs. 3), and distress (0 vs. 4) were lower for MACE than for EGD (P < 0.001). Conclusion Combined examination of the upper GI tract and small bowel using the MACE capsule detected more pathology than EGD alone in patients with recurrent or refractory IDA. MACE also had a higher diagnostic yield than EGD in the upper GI tract and was better tolerated by patients.


Sign in / Sign up

Export Citation Format

Share Document